Clinical Trial Update: Use of Indocyanine Green (ICG) for the Diagnosis of Biliary Atresia [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update describes ongoing Phase 1 and Phase 2 studies evaluating the use of indocyanine green dye for diagnosing biliary atresia. The study i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Atresia

Drugs mentioned

• Indocyanine Green (Indocyanine Green)

Snippet

Sponsor: Boston Children's Hospital | Conditions: Biliary Atresia | Phase 1, Phase 2 | Status: RECRUITING